Compounds > opc 14117
Page last updated: 2024-08-24

opc 14117 and AIDS Dementia Complex

opc 14117 has been researched along with AIDS Dementia Complex in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Trials

2 trial(s) available for opc 14117 and AIDS Dementia Complex

ArticleYear
Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.
    Neurology, 1997, Volume: 49, Issue:1

    Topics: Adult; AIDS Dementia Complex; Antioxidants; Double-Blind Method; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Prognosis

1997
Vitamin E drug.
    Treatment review, 1995, Issue:no 18

    Topics: AIDS Dementia Complex; Antioxidants; Cognition Disorders; Free Radical Scavengers; HIV Infections; Humans; Indans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Vitamin E

1995